APA (7th ed.) Citation

Vincenzi, B., Napolitano, A., Fiocco, M., Mir, O., Rutkowski, P., Blay, J., . . . Casali, P. G. (2022). Adjuvant imatinib in patients with GIST harboring exon 9 KIT mutations: Results from a multi-institutional European retrospective study : translational cancer mechanisms and therapy. Clinical cancer research, 28(8), . https://doi.org/10.1158/1078-0432.CCR-21-1665

Chicago Style (17th ed.) Citation

Vincenzi, Bruno, et al. "Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations: Results from a Multi-institutional European Retrospective Study : Translational Cancer Mechanisms and Therapy." Clinical Cancer Research 28, no. 8 (2022). https://doi.org/10.1158/1078-0432.CCR-21-1665.

MLA (9th ed.) Citation

Vincenzi, Bruno, et al. "Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations: Results from a Multi-institutional European Retrospective Study : Translational Cancer Mechanisms and Therapy." Clinical Cancer Research, vol. 28, no. 8, 2022, https://doi.org/10.1158/1078-0432.CCR-21-1665.